Aptose Biosciences Files Proxy Statement, Announces Online Only Annual General Meeting

SAN DIEGO and TORONTO, April 24, 2020 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (?Aptose? or the??Company?) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated agents that target the underlying mechanisms of cancer, announced today that it has filed its proxy statement for the 2020 annual general meeting of shareholders.